Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.
Linders DGJ, Bijlstra OD, Fallert LC, Hilling DE, Walker E, Straight B, March TL, Valentijn ARPM, Pool M, Burggraaf J, Basilion JP, Vahrmeijer AL, Kuppen PJK. Linders DGJ, et al. Among authors: pool m. Mol Imaging Biol. 2023 Feb;25(1):58-73. doi: 10.1007/s11307-022-01768-4. Epub 2022 Aug 24. Mol Imaging Biol. 2023. PMID: 36002710 Free PMC article. Review.
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.
Pool M, Terwisscha van Scheltinga AGT, Kol A, Giesen D, de Vries EGE, Lub-de Hooge MN. Pool M, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1328-1336. doi: 10.1007/s00259-017-3672-x. Epub 2017 Mar 19. Eur J Nucl Med Mol Imaging. 2017. PMID: 28315949 Free PMC article.
Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model.
Dell'Oglio P, van Willigen DM, van Oosterom MN, Bauwens K, Hensbergen F, Welling MM, van der Stadt H, Bekers E, Pool M, van Leeuwen P, Maurer T, van Leeuwen FWB, Buckle T. Dell'Oglio P, et al. Among authors: pool m. EJNMMI Res. 2022 Mar 7;12(1):14. doi: 10.1186/s13550-022-00886-y. EJNMMI Res. 2022. PMID: 35254544 Free PMC article.
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial.
Dotinga M, Vriens D, van Velden FHP, Stam MK, Heemskerk JWT, Dibbets-Schneider P, Pool M, Rietbergen DDD, de Geus-Oei LF, Kapiteijn E. Dotinga M, et al. Among authors: pool m. Diagnostics (Basel). 2022 Dec 14;12(12):3154. doi: 10.3390/diagnostics12123154. Diagnostics (Basel). 2022. PMID: 36553163 Free PMC article.
186 results